PA5-22997
antibody from Invitrogen Antibodies
Targeting: BIRC3
API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunocytochemistry [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-22997 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- cIAP2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Suggested positive control: Hela whole cell lysate; Jurkat whole cell lysate.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1.5 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
Turner JG, Kashyap T, Dawson JL, Gomez J, Bauer AA, Grant S, Dai Y, Shain KH, Meads M, Landesman Y, Sullivan DM
Oncotarget 2016 Nov 29;7(48):78896-78909
Oncotarget 2016 Nov 29;7(48):78896-78909
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of cIAP2 using a polyclonal antibody (Product # PA5-22997).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry analysis of cIAP2 in HeLa cells. Samples were incubated in cIAP2 polyclonal antibody (Product # PA5-22997) followed by DyLight 488 labeled secondary antibody (Green). Hoechst 33258 nuclear counterstain (Blue).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of cIAP2 in human adenocarcinoma cells and adjacent glands. Samples were incubated in cIAP2 polyclonal antibody (Product # PA5-22997).